Achieved Good Response of S-1 and Docetaxel Combination Chemotherapy in Two Patients With Metastatic Extramammary Paget's Disease

Journal of Dermatology - United States
doi 10.1111/1346-8138.13693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Case of Metastatic Extramammary Paget's Disease Treated With Trastuzumab‐biosimilar Monotherapy After S‐1 and Docetaxel Combination Chemotherapy

Journal of Dermatology
DermatologyMedicine
2019English

Combination Cisplatin‐Epirubicin‐Paclitaxel Therapy for Metastatic Extramammary Paget's Disease

Oncologist
Cancer ResearchMedicineOncology
2019English

A Statistical Study of 55 Patients With Extramammary Paget's Disease

Skin Cancer
2005English

Tissue of Extramammary Paget's Disease. Histological Examination of Position Showing Decolorization Spot of Extramammary Paget's Disease.

Skin Cancer
1996English

Outcome of Combination Chemotherapy With Docetaxel, Estramustine Phosphate, and Carboplatin After Docetaxel and Prednisolone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Journal of Cancer Therapy
2016English

The Expression of EpCAM in Extramammary Paget's Disease

Intractable and Rare Diseases Research
Medicine
2019English

Extramammary Paget's Disease: Outcome of Radiotherapy With Curative Intent

Clinical and Experimental Dermatology
Dermatology
2003English

Penoscrotal Extramammary Paget's Disease: Surgical Techniques and Follow-Up Experiences With Thirty Patients

Asian Journal of Andrology
MedicineUrology
2013English

Low-Dose 5-Fluorouracil/Cisplatin Therapy as Conversion Chemotherapy for Advanced Extramammary Paget's Disease

Kaohsiung Journal of Medical Sciences
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy